---
title: 'Director, Marketing at IMVT Corporation'
canonical: 'https://feeny.ai/job/director-marketing-imvt-corporation-remote-4t6kt28mgdh0'
type: 'job'
last_seen: '2026-09-11'
---

# Director, Marketing at IMVT Corporation

- **Company:** IMVT Corporation
- **Location:** Remote
- **Compensation:** $210k–$250k
- **Work type:** remote
- **Posted:** 2026-03-19
- **Last confirmed live:** 2026-09-11
- **Apply:** https://job-boards.greenhouse.io/imvtcorporation/jobs/5829722004

## Job description

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases.

The Role:

The Director of Product Marketing is critical to the success of the commercial launch of IMVT-1402 and the successful transformation of the company from a clinical-stage company to a commercial-stage company.  Reporting to the Senior Vice President of Commercial, this position helps build strategic and tactical launch plans for IMVT-1402 in Graves’ Disease.

Key Responsibilities:

Product Marketing

- Develop an insight driven marketing strategy and positioning for the brand through the application of a strategic framework that relies on key leverage points and strategic choices to determine targeting scenarios.
- Lead cross functional team, build and shape all launch plans to ensure organizational readiness and success
- Partner closely with Business Analytics to develop robust market research plan to ensure market insights and competitive intelligence are included in all plans and forecast assumptions.
- Partner with Analytics to shape market research, inform key performance metrics, and measure the effectiveness of marketing initiatives.
- Develop and implement tactics aligned to the brand strategic choices and key leverage points. Ensure alignment with product positioning, and messaging across targeted HCP and consumer tactics while maintaining a high standard of quality and compliance for Immunovant.
- Lead the implementation of a disease educational campaign shaping the market for a new entrant and catalyzing a change in Graves’ Disease understanding and treatment approach
- Lead implementation of brand/launch strategies through development of effective promotional materials for key customer segments (e.g., HCPs, patients, KOLs, allied health professionals, market access stakeholders) and across multiple channels.
- Partner with digital marketing to establish all multi-channel specific strategies and tactics including those necessary to support the Customer Engagement team e.g.: face to face, digital, CRM etc.
- Maintain expertise in disease state, competitive landscape, and market dynamics, informing potential pivots in strategic and executional approach as needed
- Responsible for the management and evaluation of key agencies and vendors

Requirements:

- BA/BS required; MBA and/or other relevant graduate degree preferred
- 8+ years of marketing experience in a biotechnology or pharmaceutical organization. Launch experience required
- Track record of enterprise influence - able to lead through ambiguity, align diverse stakeholders, and drive decisions across functions outside of direct reporting lines.
- Strong communication skills; able to synthesize complex inputs into clear recommendations for senior leadership.
- Demonstrated analytical and problem-solving skills, leading to the development of innovative marketing initiatives.

Work Environment:

- Remote
- Dynamic, interactive, fast-paced, and entrepreneurial environment
- Domestic or international travel are required (20% - 25%)

Salary range for posting $210,000—$250,000 USD

Compensation is based on a number of factors, including market location, and may vary depending on job-related knowledge, skills, and experience. Equity and other forms of compensation may be provided as part of a total compensation package, in addition to a full range of medical, dental, vision, 401k, and other benefits, including unlimited paid time off and parental leave.

## About IMVT Corporation

## Company Overview
- **One-liner**: A clinical-stage immunology company developing innovative anti-FcRn therapies to enable normal lives for people with autoimmune diseases.
- **Entity Type**: Public (Nasdaq: IMVT)
- **Headquarters**: Durham, North Carolina, United States
- **Founded**: Not publicly available
- **Founders**: Not publicly available

## Core Business
- **Primary industry**: Biotechnology / Autoimmune disease therapeutics
- **Target customers**: Patients with IgG-mediated autoimmune diseases; healthcare providers; payers (B2B/B2C mix via prescription drugs)
- **Mission or purpose statement**: “Dedicated to enabling normal lives for people with autoimmune diseases” [immunovant.com](https://www.immunovant.com/)

## Products & Services
- **[IMVT-1402 (imeroprubart)]**: A novel, fully human monoclonal antibody that targets FcRn to reduce pathogenic IgG autoantibodies. Designed as a subcutaneous injection with a simple autoinjector (YpsoMate®). In clinical development for six indications: Graves’ disease (GD), difficult-to-treat rheumatoid arthritis (D2T RA), myasthenia gravis (MG), chronic inflammatory demyelinating polyneuropathy (CIDP), Sjögren’s disease (SjD), and cutaneous lupus erythematosus (CLE). [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)
- **[Batoclimab (first-generation anti-FcRn)]**: Development discontinued across all indications after Phase 3 TED trials did not meet primary endpoints; learnings inform IMVT-1402 program. [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Market Standing
- **Valuation/Market Cap**: Not disclosed in available sources (publicly traded on Nasdaq; refer to real-time market data).
- **Key Metric**: Clinical-stage company with no approved products or revenue; total funding and operating expenses are detailed in SEC filings but not summarized here.
- **Notable Investors/Partners**: HanAll Biopharma (collaboration on anti-FcRn antibodies); Ypsomed AG (auto-injector YpsoMate®). [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)
- **Growth Signals**: Six ongoing clinical programs (including potentially registrational trials); deep IgG reductions (~80% with weekly 600 mg IMVT-1402) suggesting best-in-class potential; Phase 1 safety data showing no/minimal albumin reduction or LDL cholesterol increases. [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Competitive Advantages
- **Potential best-in-class efficacy**: IMVT-1402 achieves deeper IgG reductions than competitor anti-FcRn antibodies, correlating with improved clinical outcomes.
- **Favorable safety profile**: No or minimal off-target effects on albumin and LDL cholesterol, unlike some FcRn inhibitors.
- **Convenient administration**: Self-administered subcutaneous autoinjector (YpsoMate®) expected at launch, improving patient adherence.
- **Broad pipeline**: Six indications in development across endocrinology, rheumatology, neurology, and dermatology, with potential for more.

## Strategic Focus
- Execute pivotal trials for IMVT-1402 in GD, D2T RA, MG, CIDP, SjD, and CLE.
- Leverage learnings from batoclimab program to accelerate IMVT-1402 development.
- Plan to assess new indications for IMVT-1402 beyond the initial six.
- Continue to build commercial capabilities for eventual launch. [10-K (2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Why Work Here
- **Culture**: Emphasizes “Hire and Retain Only the Very Best,” “One Team, Shared Success,” “Ownership Mentality,” and “Patients Are Waiting” – a mission-driven, high-performance environment. [About Us](https://www.immunovant.com/about-us)
- **Remote/Hybrid Policy**: Job listings show a mix of remote and hybrid roles (e.g., “Remote” for many positions, “Hybrid - NYC” for commercial roles). [Careers](https://www.immunovant.com/join-us/explore-careers)
- **Notable Perks**: Merit-based recognition, focus on impact and results, creative problem-solving encouraged. [About Us](https://www.immunovant.com/about-us)
- **Engineering/Science Culture**: Clinical-stage biotech with cutting-edge FcRn technology; opportunities in clinical development, biometrics, quality assurance, and commercial roles. [Careers](https://www.immunovant.com/join-us/explore-careers)

## Sources
1. [Immunovant Corporate Website](https://www.immunovant.com/)
2. [About Us – Values and Culture](https://www.immunovant.com/about-us)
3. [Company Information – Investor Relations](https://www.immunovant.com/investors/company-information)
4. [Explore Careers – Job Listings](https://www.immunovant.com/join-us/explore-careers)
5. [10-K SEC Filing (May 20, 2026)](https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf)

## Other roles at IMVT Corporation

- [Senior Director, Data Management Systems](https://feeny.ai/job/senior-director-data-management-systems-imvt-corporation-remote-bw7zc2r5bz1x)
- [Associate Director, Supply Chain Product Planning](https://feeny.ai/job/associate-director-supply-chain-product-planning-imvt-corporation-remote-xhnnchmc99f3)
- [Executive Assistant](https://feeny.ai/job/executive-assistant-imvt-corporation-new-york-m7dv0wr8rkjs) — New York, NY
- [Senior Manager, QC](https://feeny.ai/job/senior-manager-qc-imvt-corporation-remote-a2g9683h4zsg)
- [Senior Director, Biostatistics](https://feeny.ai/job/senior-director-biostatistics-imvt-corporation-remote-swdw529e6zxr)
- [Director, Medical Science Liaison (MSL)](https://feeny.ai/job/director-medical-science-liaison-msl-imvt-corporation-southeast-cnykwbftkpjw) — Southeast
- [Director, Marketing](https://feeny.ai/job/director-marketing-lalamove-hong-kong-s5h88b3de65m) — Hong Kong, China
- [Director, Marketing](https://feeny.ai/job/director-marketing-synapticure-united-states-xd7dgc4xkaqw) — United States
- [Director, Marketing](https://feeny.ai/job/director-marketing-cala-health-san-francisco-rw9qtt342wgy) — San Francisco, CA